Atlas Trials

FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation

Clinical trial NCT05246618 · COMPLETED

Trial details

NCT number
NCT05246618
Sponsor
iCoat Medical AB
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ischemia-reperfusion InjuryKidney Transplant; Complications
Start date
2022-03-31
Primary completion
2023-07-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.